Article Versions Notes

Duan R, Liu Y, Tang D, Lin R, Huang J, Zhao M. IgG1 Is the Optimal Subtype for Treating Atherosclerosis by Inducing M2 Macrophage Differentiation, and Is Independent of the FcγRIIA Gene Polymorphism. International Journal of Molecular Sciences. 2023; 24(6):5932. https://doi.org/10.3390/ijms24065932

Duan, Rui, Yan Liu, Dongmei Tang, Run Lin, Jinrong Huang, and Ming Zhao. 2023. "IgG1 Is the Optimal Subtype for Treating Atherosclerosis by Inducing M2 Macrophage Differentiation, and Is Independent of the FcγRIIA Gene Polymorphism" International Journal of Molecular Sciences 24, no. 6: 5932. https://doi.org/10.3390/ijms24065932

Duan, R., Liu, Y., Tang, D., Lin, R., Huang, J., & Zhao, M. (2023). IgG1 Is the Optimal Subtype for Treating Atherosclerosis by Inducing M2 Macrophage Differentiation, and Is Independent of the FcγRIIA Gene Polymorphism. International Journal of Molecular Sciences, 24(6), 5932. https://doi.org/10.3390/ijms24065932